Literature DB >> 11516996

The calpain family and human disease.

Y Huang1, K K Wang.   

Abstract

The number of mammalian calpain protease family members has grown to 14 on last count. Overactivation of calpain 1 and calpain 2 (and their small subunit) has long been tied to acute neurological disorders (e.g. stroke and traumatic brain injury) and recently to Alzheimer's disease. Loss-of-function mutations of the calpain 3 gene have now been identified as the cause of limb-girdle muscular dystrophy 2A. Calpain 10 was recently identified as a susceptibility gene for type 2 diabetes, whereas calpain 9 appears to be a gastric cancer suppressor. This review describes our current understanding of the calpain family members and their mechanistic linkages to the aforementioned diseases as well as other emerging pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516996     DOI: 10.1016/s1471-4914(01)02049-4

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  126 in total

1.  Targeting proteases in atherosclerosis: hitting the nail with the hammer.

Authors:  Daniel I Simon; Mukesh K Jain
Journal:  Circulation       Date:  2011-12-06       Impact factor: 29.690

2.  MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts.

Authors:  Bruce D Cuevas; Amy N Abell; James A Witowsky; Toshiaki Yujiri; Nancy Lassignal Johnson; Kamala Kesavan; Marti Ware; Peter L Jones; Scott A Weed; Roberta L DeBiasi; Yoshitomo Oka; Kenneth L Tyler; Gary L Johnson
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

3.  Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions.

Authors:  Graciela Fuertes; José Javier Martín De Llano; Adoración Villarroya; A Jennifer Rivett; Erwin Knecht
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

4.  Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway.

Authors:  Dhanesh Pitidhammabhorn; Surasak Kantachuvesiri; Kitti Totemchokchyakarn; Yindee Kitiyanant; Sukathida Ubol
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

5.  Homodimerization of calpain 3 penta-EF-hand domain.

Authors:  Ravikiran Ravulapalli; Beatriz Garcia Diaz; Robert L Campbell; Peter L Davies
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

6.  Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta -catenin-regulated cell proliferation.

Authors:  Guangnan Li; Ravi Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

7.  Involvement of calpain-calpastatin in cigarette smoke-induced inhibition of lung endothelial nitric oxide synthase.

Authors:  Zhaoqiang Cui; Zhaosheng Han; Zhaozhong Li; Hanbo Hu; Jawaharlal M Patel; Veena Antony; Edward R Block; Yunchao Su
Journal:  Am J Respir Cell Mol Biol       Date:  2005-08-11       Impact factor: 6.914

8.  Mitigating the Metabolic Liability of Carbonyl Reduction: Novel Calpain Inhibitors with P1' Extension.

Authors:  Andreas Kling; Katja Jantos; Helmut Mack; Wilfried Hornberger; Gisela Backfisch; Yanbin Lao; Marjoleen Nijsen; Beatrice Rendenbach-Mueller; Achim Moeller
Journal:  ACS Med Chem Lett       Date:  2018-02-04       Impact factor: 4.345

9.  Limitations of SLLVY-AMC in calpain and proteasome measurements.

Authors:  Christopher J Giguere; Rick G Schnellmann
Journal:  Biochem Biophys Res Commun       Date:  2008-05-05       Impact factor: 3.575

10.  Characterization of endogenous and recombinant human calpain-10.

Authors:  Biao Dong; Rihe Liu
Journal:  Biochimie       Date:  2008-04-10       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.